Synapse - Craig Moskowitz

Search Within

Craig Moskowitz

Results (93)

Negative interim FDG-PET scan is predictive of superior outcome in T cell lymphoma

Meeting Abstract

Casulo, C.; Zelenetz, A. D.; Moskowitz, C. H.; Horwitz, S. M.
Blood (2009)

Bendamustine is highly active in heavily pre-treated relapsed and refractory Hodgkin lymphoma and serves as a bridge to allogeneic stem cell transplant

Meeting Abstract

Moskowitz, A. J.; Hamlin, P. A.; Gerecitano, J.; Horwitz, S. M.; Matasar, M.; Meikle, J.; Noy, A.; Palomba, M. L.; Portlock, C. S.; Straus, D. J.; more...
Blood (2009)

Fulltext@MSK | Save

Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies

Journal Article

O'Connor, O. A.; Horwitz, S.; Hamlin, P.; Portlock, C.; Moskowitz, C. H.; Sarasohn, D.; Neylon, E.; Mastrella, J.; Hamelers, R.; Macgregor-Cortelli, B.; more...
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Pralatrexate (PDX) produces a high and durable complete response rate in patients with chemotherapy resistant T-cell lymphomas

Meeting Abstract

O'Connor, O. A.; Hamlin, P.; Moskowitz, C.; Portlock, C.; Sarasohn, D.; Dumitrescu, O.; Neylon, E.; Patterson, M.; Zelenetz, A.; Saunders, M.; more...
Annals of Oncology (2008)

Fulltext@MSK | Save

Normalization of FDG-PET pre-ASCT with additional non-cross resistant chemotherapy improves EFS in patients with relapsed and primary refractory Hodgkin lymphoma - Memorial Sloan Kettering protocol 04-047

Meeting Abstract

Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; Portlock, C. S.; Straus, D. J.; Gerecitano, J.; Kewalramani, T.; more...
Blood (2008)

Fulltext@MSK | Save

Psychological distress in long-term survivors of hematopoietic stem cell transplantation

Journal Article

Rusiewiczu, A.; Duhamel, K. N.; Burkhalter, J.; Ostroff, J.; Winkel, G.; Scigliano, E.; Papadopoulos, E.; Moskowitz, C.; Redd, W.
Psycho-Oncology (2008)

Fulltext@MSK | Save

Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell lymphoma: Long-term disease control and toxicity

Journal Article

Hoppe, B. S.; Moskowitz, C. H.; Filippa, D. A.; Moskowitz, C. S.; Kewalramani, T.; Zelenetz, A. D.; Yahalom, J.
Journal of Clinical Oncology (2008)

Fulltext@MSK | Save

Vaccine efficacy following autologous peripheral blood stem cell transplant for lymphoma

Meeting Abstract

Small, T. N.; Rice, R. D.; Mccullagh, E.; Noy, A.; Trippett, T.; Horwitz, S. M.; Zelenetz, A. D.; Moskowitz, C.
Blood (2007)

Fulltext@MSK | Save

A phase '2-1-2' study of two different doses and schedules of pralatrexate, a high affinity substrate for the reduced folate carrier (RFC-1), in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies

Meeting Abstract

O'Connor, O. A.; Hamlin, P.; Portlock, C.; Moskowitz, C.; Noy, A.; Straus, D.; Dumetrescu, O.; Sarasohn, D.; Neylon, E.; Hamelers, R.; more...
Molecular Cancer Therapeutics (2007)

Fulltext@MSK | Save

Late relapses characterize autologous transplantation (ASCT) in first complete remission (CR) for peripheral T-cell lymphoma (PTCL)

Meeting Abstract

Kewalramani, T.; Horwitz, S.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
Blood (2007)

Fulltext@MSK | Save